• Margaret M Paul, Lorraine Kwok, Rachel E Massar, Michelle Chau, Rita Larson, Stefanie Bendik, Lorna E Thorpe, Anna Bershteyn, Nadia Islam, and Carolyn A Berry.
• Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA. paul.margaret@mayo.edu.
• J Urban Health. 2024 Oct 1; 101 (5): 888897888-897.

AbstractOn June 1, 2020, NYC Health + Hospitals, in partnership with the NYC Department of Health and Mental Hygiene, other city agencies, and a large network of community partners, launched the New York City Test & Trace (T2) COVID-19 response program to identify and isolate cases, reduce transmission through contact tracing, and provide support to residents during isolation or quarantine periods. In this paper, we describe lessons learned with respect to planning and implementation of case notification and contact tracing. Our findings are based on extensive document review and analysis of 74 key informant interviews with T2 leadership and frontline staff, cases, and contacts conducted between January and September 2022. Interviews elicited respondent background, history of program development, program leadership and structure, goals of the program, program evolution, staffing, data systems, elements of community engagement, trust with community, program reach, timeliness, equity, general barriers and challenges, general facilitators and best practices, and recommendations/improvement for the program. Facilitators and barriers revealed in the interviews primarily revolved around hiring and managing staff, data and technology, and quality of interactions with the public. Based on these facilitators and barriers, we identify suggestions to support effective planning and response for future case notification and contact tracing programs, including recommendations for planning during latent periods, case management and data systems, and processes for outreach to cases and contacts.© 2024. The New York Academy of Medicine.

15 keywords...

hide…